1 Small-Cap Stock with Competitive Advantages and 2 We Avoid
Sotera Health Company’s (NASDAQ:SHC) Q4 CY2025: Beats On Revenue
2025 net revenues increased 5.7% to $1.164 billion , compared to 2024, or 5.2% on a constant currency basis 2025 net income increased to $78 million or $0.27 per diluted share, compared to...
Sotera Health Company (SHC) Q4 Earnings Report Preview: What To Look For
CLEVELAND, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for...
CLEVELAND, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for...
Sotera Health Company (SHC): Buy, Sell, or Hold Post Q3 Earnings?
1 Momentum Stock with Competitive Advantages and 2 That Underwhelm
CLEVELAND, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions,...